BALSAM Delegates Approve 2026 Profit Distribution
Balsam Al-Ufuq Medical Company approved delegating the Board of Directors to distribute interim profits to shareholders on a semi-annual or quarterly basis for the year 2026, during the Ordinary General Assembly meeting, which was attended by a quorum of 78.74%. The Board of Directors’ report and the financial statements for the year 2025 were also approved. Additionally, the auditors for 2026 were appointed with fees amounting to 170,000 Saudi Riyals.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)